DISEASE SCANNER
Global Incurable Diseases Tracker
Hypertrophic Cardiomyopathy (HCM)
A genetic condition characterized by abnormal thickening (hypertrophy) of the heart muscle, most commonly the interventricular septum. Can obstruct blood flow and cause arrhythmias. Leading cause of sudden cardiac death in young athletes.
2.0M
16
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Echocardiogram (asymmetric septal hypertrophy)
- 2Cardiac MRI
- 3Genetic testing
- 4ECG (LVH, ST-T changes)
- 5Exercise stress testing
- 6Holter monitoring
Prognosis
Generally good with modern management; annual mortality 1-2% in adults. Higher risk in children and young adults. ICD prevents sudden death in high-risk patients. Most live normal lifespan.
Prevention
- Genetic counseling and testing
- Family screening
- Avoidance of competitive sports (high-risk patients)
- ICD for primary prevention in high-risk
- Treatment of hypertension
Research Status
Beta-blockers, non-dihydropyridine calcium channel blockers for symptoms. ICD for high-risk patients. Septal myectomy or alcohol septal ablation for obstruction. Mavacamten (cardiac myosin inhibitor) newly approved.
Affected Countries
Sources
- https://www.heart.org/en/health-topics/cardiomyopathy/what-is-cardiomyopathy-in-adults/hypertrophic-cardiomyopathy-hcm
- https://www.hematology.org/education/patients
- https://www.ncbi.nlm.nih.gov/books
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.